Axogen, Inc. — Director's Dealing 2011

Oct 12, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (LECT)
CIK: 0000805928
Period of Report: 2011-10-10

Reporting Person: Mandato Joseph M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-10-10	Common Stock	A	5455	$2.75	Acquired	5455	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-10-10	Stock Option	$2.75	A	12000	Acquired	2018-10-10	Common Stock (12000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1426392	Indirect

Footnotes

F1: These shares were granted in lieu of cash payment to Mr. Mandato, a non-employee director, as compensation for his service through December 31, 2012.

F2: The shares are owned by De Novo Ventures II, L.P. ("De Novo"). De Novo Management II, LLC is the sole general partner of De Novo. The reporting person is a managing member of De Novo Management II, LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

F3: Options granted as compensation for service on the board of directors. All options vested on the date of grant.